Innovating Works

TATAA

Desconocido
OPTOMICS: Combining optoacoustic imaging phenotypes and multi omics to advance diabetes healthcare TATAA BIOCENTER AB participó en un H2020 H2020-FETPROACT-2018-2020 Diabetes has emerged as a global pandemic affecting more than 420 million people worldwide, a number expected to further rise in the next de...
2020-12-16 - 2026-12-31 | Financiado
CORONADX: Three Rapid Diagnostic tests Point of Care for COVID 19 CoronaThree Rapid Diagnostic tests Point... TATAA BIOCENTER AB participó en un H2020 H2020-SC1-PHE-CORONAVIRUS-2020 On 30th January 2020 WHO declared a global health emergency for the outbreak of the 2019 novel Coronavirus (COVID-19, or 2019-nCoV) that ori...
2020-04-08 - 2023-09-30 | Financiado
PainFACT: Molecular Mechanisms Associating Chronic Pain with Fatigue Affective Disorders Cardiovascular Dise... Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression ─ also major contribut...
2019-11-22 - 2025-12-31 | Financiado
PITBUL: Point of Care implementation of TB testing with ultra fast Local Heating PCR TATAA BIOCENTER AB participó en un H2020 H2020-NMBP-2016-2017 The overall goal of this project is to bring the unique, ultra-fast Local Heating PCR technology and its current lab-proven prototype instru...
2017-11-09 - 2020-11-30 | Financiado
ELBA: European Liquid Biopsies Academy Towards widespread clinical application of blood based diagnosti... TATAA BIOCENTER AB participó en un H2020 H2020-MSCA-ITN-2017 Liquid biopsies have been heralded as a game changer in cancer management, with blood tests offering a minimally invasive, safe, and sensiti...
2017-08-30 - 2022-09-30 | Financiado
SPIDIA4P: SPIDIA for Personalized Medicine Standardisation of generic Pre analytical procedures for In vitro... TATAA BIOCENTER AB participó en un H2020 H2020-SC1-2016-2017 Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited...
2016-11-30 - 2021-06-30 | Financiado
SMARTDIAGNOS: Next generation sepsis diagnosis TATAA BIOCENTER AB participó en un H2020 H2020-ICT-2015 Sepsis is a potentially fatal condition that arises when the body’s response to an infection damages its own tissues and organs. It is mainl...
2015-12-09 - 2020-01-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TATAA BIOCENTER AB participó en un FP6 Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado
EPITRAIN: Epigenetic Training Network Innovative techniques and models to understand epigenetic regulation i... TATAA BIOCENTER AB participó en un FP7 "Despite the past century witnessing considerable advances in our understanding of genetics, the success of genome-wide association studies...
Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TATAA BIOCENTER AB participó en un FP7 Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
Financiado
LabOnFoil: Laboratory Skin Patches and SmartCards based on foils and compatible with a smartphone TATAA BIOCENTER AB participó en un FP7 Conventional analytical methods often require a large sample volume and complicated time-consuming protocols. The objective of this project...
Financiado
EDU-GLIA: Innovative Techniques and Models to Study Glia Neuron Interactions TATAA BIOCENTER AB participó en un FP7 It became evident over the last 20 years that glial cells are involved in virtually every aspect of nervous system function. Neurons and gli...
Financiado
HOMAGE: Heart OMics in AGEing TATAA BIOCENTER AB participó en un FP7 As more people survive into old age, the prevalence of heart failure (HF), one of the most common and debilitating diseases in older people,...
Financiado
EURHEALTHAGEING: European ResearcH on DevElopmentAL BirtH and Genetic Determinants of Ageing TATAA BIOCENTER AB participó en un FP7 Developmental plasticity modulated by epigenetic processes such as methylation and post-translational modifications is influenced by early l...
Financiado
SPIDIA: Standardisation and improvement of generic pre analytical tools and procedures for in vitro diagnost... TATAA BIOCENTER AB participó en un FP7 In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collect...
Financiado
CD-MEDICS: Coeliac Disease Management Monitoring and Diagnosis using Biosensors and an Integrated Chip Syst... TATAA BIOCENTER AB participó en un FP7 The overall concept of the CD-MEDICS IP is to develop a technology platform for point-of-care diagnostics, capable of simultaneous genomic a...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.